Sharon Wagamon
Hematology & Oncology · Geneva, OHNPI 1811107683
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,377 of the $1,531 with a category attached, or 89.9%. It is spread thinly across 32 manufacturers, the largest accounting for just 8.8% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for hematology & oncology clinicians in OH, where the typical reported total is $2,354.
Across 87 payments — averaging $17.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$135
- Genentech USA, Inc.$129
- Merck$123
- Novartis$117
- Bristol Myers Squibb$100
- Comsort, Inc$100
- plus $827 from 26 others
What the payments were for
- Consulting fees$1007%
- Food & beverage$1,37790%
- Education$554%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 11 | $135 |
| Genentech USA, Inc. | 8 | $129 |
| Merck | 8 | $123 |
| Novartis | 7 | $117 |
| Bristol Myers Squibb | 6 | $100 |
| Comsort, Inc | 1 | $100 |
| AstraZeneca | 4 | $69 |
| Sanofi | 4 | $62 |
| Eisai Inc. | 3 | $62 |
| Amgen | 3 | $59 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $52 |
| Lilly USA, LLC | 3 | $46 |
| AMAG Pharmaceuticals, Inc. | 2 | $43 |
| Ipsen Biopharmaceuticals, Inc | 2 | $40 |
| Johnson & Johnson | 2 | $40 |
| Mylan Institutional Inc. | 2 | $39 |
| Astellas Pharma US Inc | 2 | $35 |
| Verastem, Inc. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Exelixis Inc. | 1 | $24 |
| Foundation Medicine, Inc. | 1 | $22 |
| Bayer | 1 | $20 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $18 |
| Agios Pharmaceuticals, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Partner Therapeutics, Inc. | 1 | $16 |
| Incyte Corporation | 1 | $16 |
| Pfizer | 1 | $13 |
| Clovis Oncology, Inc. | 1 | $13 |
| Tesaro, Inc. | 1 | $12 |
| Rigel Pharmaceuticals, Inc. | 1 | $12 |
| Puma Biotechnology, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KEYTRUDA$100
How this compares
$1,531 in reported general payments places this provider in the 40th percentile of 450 hematology & oncology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Chloride | 12 | $240 |
| Anastrozole | 19 | $177 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Geneva
- Hillard LazarusCleveland$2M
- Kasra KaramlouSandusky$1.8M
- David WaterhouseCincinnati$1.3M
- Taral PatelColumbus$888K
- Tarek ChidiacColumbus$765K
- Saulius GirniusMontgomery$707K
- Ronald BukowskiCleveland$594K
- Balazs HalmosCleveland$568K
- Jorge GarciaCleveland$513K
- Alejandro CalvoKettering$463K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.